BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,020.00
-25.00 (-0.82%)
Sep 4, 2026, 3:16 PM KST

BCWORLD PHARM. Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,8635,8845,4446,9964,0322,756
Short-Term Investments
1,0799272,4674,1704,0251,746
Cash & Short-Term Investments
4,9436,8117,91111,1668,0584,503
Cash Growth
-12.23%-13.91%-29.14%38.57%78.97%-64.15%
Accounts Receivable
17,77718,73620,29718,19016,51115,047
Other Receivables
1,7131,534589.67648.151,267880.31
Receivables
19,49020,27020,88719,48317,77815,927
Inventory
22,81721,30614,84417,09616,78716,147
Prepaid Expenses
733.45578.49884.88250.24406.41363.9
Other Current Assets
156.14110.4930.6891.07579.46294.04
Total Current Assets
48,13949,07544,55848,08643,60937,235
Property, Plant & Equipment
116,515117,852120,985125,628130,119132,370
Long-Term Investments
1,7762,6162,9211,7841,3623,756
Other Intangible Assets
2,2542,5442,7112,9972,8282,266
Long-Term Deferred Tax Assets
4,6984,5114,9465,4594,9793,145
Other Long-Term Assets
231.13203.84192.37157.07154.27586.78
Total Assets
173,613176,801176,313184,111183,051179,358

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
6,8467,7323,8724,2324,0672,686
Accrued Expenses
3,7434,3923,915425.32456.14556.95
Short-Term Debt
65,46360,34068,60658,21646,05039,730
Current Portion of Long-Term Debt
10,16711,9175,65321,43326,8175,405
Current Portion of Leases
348.05340.99256.72196.8262.8766.58
Current Income Taxes Payable
111.33495.8384.71136.93-133.13
Other Current Liabilities
4,8754,4963,4777,6066,7537,314
Total Current Liabilities
91,55389,71385,86592,24684,20655,892
Long-Term Debt
-14,00013,91711,57021,17043,686
Long-Term Leases
-567.5521.27424.88154.87132.15
Other Long-Term Liabilities
10,69718.85-000-0
Total Liabilities
102,268104,299100,303104,241105,53199,711

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
2,1331,9471,7781,7781,7781,778
Additional Paid-In Capital
34,96134,96134,94734,94734,94734,947
Retained Earnings
33,99635,91241,52046,49544,40445,255
Treasury Stock
-1,553-1,539-1,578-1,578-1,578-771.62
Comprehensive Income & Other
0-0-0-0-0248.54
Total Common Equity
69,53671,28176,66881,64379,55281,458
Minority Interest
1,8081,221-657.38-1,774-2,032-1,811
Shareholders' Equity
71,34572,50276,01079,86977,52079,647
Total Liabilities & Equity
173,613176,801176,313184,111183,051179,358

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
75,97787,16588,95491,84194,25589,021
Net Cash (Debt)
-71,035-80,354-81,043-80,675-86,197-84,518
Net Cash Growth
------
Net Cash Per Share
-7624.79-8648.57-8739.62-7901.05-8359.02-8180.51
Filing Date Shares Outstanding
10.229.299.2810.2110.2110.33
Total Common Shares Outstanding
10.229.2910.2110.2110.2110.33
Working Capital
-43,414-40,638-41,307-44,161-40,597-18,658
Book Value Per Share
6806.167669.367508.607995.867791.067884.29
Tangible Book Value
67,28368,73773,95778,64676,72479,192
Tangible Book Value Per Share
6585.587395.667243.127702.337514.147664.98
Land
17,13817,13817,13817,13817,13811,773
Buildings
65,80066,78968,81971,97473,79251,199
Machinery
27,49628,38728,37630,34533,65436,336
Construction In Progress
1,334972.32983.43278.23593.4328,346